血脂异常对急性胰腺炎发病影响的前瞻性队列研究

吉瑞更; 朱国玲; 张冰; 孙秋; 赵利; 李广鉴; 曹立瀛

doi:10.3969/j.issn.1001-5256.2019.07.023

血脂异常对急性胰腺炎发病影响的前瞻性队列研究

DOI: 10.3969/j.issn.1001-5256.2019.07.023

开滦总医院消化内科
开滦总医院肝胆外科

基金项目:

河北省卫生和计划生育委员会重点科技研究计划(20171437)；

详细信息

中图分类号: R576;R589.2
计量
- 文章访问数: 1278
- HTML全文浏览量: 35
- PDF下载量: 281
- 被引次数: 0
出版历程
- 收稿日期: 2019-01-30
- 出版日期: 2019-07-20

Association between dyslipidemia and acute pancreatitis: A prospective cohort study

Department of Hepatobiliary Surgery, Kailuan General Hospital, Tangshan, Hebei 063000, China

Research funding:

摘要

摘要:
目的探讨血脂异常及达到血脂异常的标准数量对新发急性胰腺炎（AP）的影响。方法采用前瞻性队列研究方法,以参加2006年-2007年健康查体的开滦集团在职及离退休职工99 695人作为观察队列,人群按首次体检（2006年-2007年）血脂异常的诊断标准分为5组:G0组（69 465例）,未达到任意1条血脂异常诊断标准; G1组（23 921例）,达到任意1条血脂异常诊断标准; G2组（5791例）,达到任意2条血脂异常诊断标准; G3组（500例）,达到任意3条血脂异常诊断标准; G4组（18例）,达到4条血脂异常诊断标准。随访期间每年收集1次新发AP病例,并采用多因素Cox比例风险回归模型分析血脂异常分组对新发AP事件的影响。计量资料多组间比较采用单因素方差分析,计数资料组间比较采用χ2检验。采用Kaplan-Meier法计算不同分组中AP的累积发病率,累积发病率的组间比较采用log-rank法。结果对99 695例观察对象的总随访时间为782 395人年,G4组人数过少无新发AP,故将G4组与G3组合并进行研究。G0～G3组AP发病率分别为1. 61/1000人年...
- 胰腺炎 /
- 血脂异常 /
- 队列研究
Abstract:
Objective To investigate the influence of dyslipidemia and number of items conforming to the diagnostic criteria for dyslipidemia on new-onset acute pancreatitis ( AP) . Methods A prospective cohort study was performed for 99 695 on-the-job or retired workers of Kailuan Group who underwent the first physical examination from 2006 to 2007. According to the number of items conforming to the diagnostic criteria for dyslipidemia in the first physical examination, they were divided into G0 group with 69 465 workers who did not meet the diagnostic criteria for dyslipidemia, G1 group with 23 921 workers who met one item of the diagnostic criteria for dyslipidemia, G2 group with5791 workers who met two items of the diagnostic criteria for dyslipidemia, G3 group with 500 workers who met three items of the diagnostic criteria for dyslipidemia, and G4 group with 18 workers who met four items of the diagnostic criteria for dyslipidemia. New-onset AP cases were collected once every year during follow-up, and a multivariate Cox proportional hazards regression model analysis was used to analyze the influence of dyslipidemia on new-onset AP cases. A one-way analysis of variance was used for comparison of continuous data between multiple groups, and the chi-square test was used for comparison of categorical data between groups. The Kaplan-Meier method was used to calculate the cumulative incidence rate of AP in each group, and the log-rank test was used for comparison of cumulative incidence rate between groups. Results The total follow-up time of all 99 695 workers was 782 395 person-years, and since no new-onset AP cases were observed in G4 group, G4 group was combined with G3 group for analysis. The incidence rates of AP in G0, G1, G2, and G3 groups were 1. 61, 2. 05, 2. 59, and 7. 72 per thousand person-years, respectively, and the cumulative incidence rates of AP in these four groups were 1. 76‰, 2. 40‰, 3. 12‰, and 8. 39‰, respectively. The log-rank test showed a significant difference in cumulative incidence rate between groups ( χ2= 15. 18, P = 0. 004 3) . After adjustment for the other risk factors, the Cox model showed that the hazard ratio ( 95%confidence interval) for AP was 1. 23 ( 0. 88-1. 73) in G1 group, 1. 58 ( 1. 09-2. 10) in G2 group, and 4. 90 ( 1. 81-13. 37) in G3 group. Conclusion Dyslipidemia is a risk factor for new-onset AP, and the risk of AP increases with the increase in the number of items conforming to the diagnostic criteria for dyslipidemia.
- pancreatitis /
- dyslipidemias /
- cohort studies

HTML全文

参考文献(24)

[1]ROBERTS SE, MORRISON-REES S, JOHN A, et al.The incidence and aetiology of acute pancreatitis across Europe[J].Pancreatology, 2017, 17 (2) :155-165.

[2]CAVALLINI G, FRULLONI L, BASSI C, et al.Prospective multicentre survey on acute pancreatitis in Italy (Pro Inf-AISP) :Results on 1005 patients[J].Dig Liver Dis, 2004, 36 (3) :205-211.

[3]GISLASON H, HORN A, HOEM D, et al.Acute pancreatitis in Bergen, Norway.A study on incidence, etiology and severity[J].Scand J Surg, 2004, 93 (1) :29-33.

[4] HONG W, ZIMMER V, BASHARAT Z, et al.Association of total cholesterol with severe acute pancreatitis:A U-shaped relationship[J].Clin Nutr, 2019.[Epub ahead of print]

[5]YADAV D, LOWENFELS AB.The epidemiology of pancreatitis and pancreatic cancer[J].Gastroenterology, 2013, 144 (6) :1252-1261.

[6] TENNER S, BAILLIE J, De WITTJ, et al.American College of Gastroenterology guideline:Management of acute pancreatitis[J].Am J Gastroenterol, 2013, 108 (9) :1400-1416.

[7]Pancreas Study Group, Chinese Society of Gastroenterology, Chinese Medical Association, Editorial Board of Chinese Journal of Pancreatology, Editorial Board of Chinese Journal of Digestion.Chinese guidelines for the management of acute pancreatitis (Shanghai, 2013) [J].J Clin Hepatol, 2013, 29 (9) :656-660. (in Chinese) 中华医学会消化病学分会胰腺疾病学组, 《中华胰腺病杂志》编辑委员会, 《中华消化杂志》编辑委员会.中国急性胰腺炎诊治指南 (2013年, 上海) [J].临床肝胆病杂志, 2013, 29 (9) :656-660.

[8] WU S, HUANG Z, YANG X, et al.Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern chinese industrial city[J].Circ Cardiovasc Qual Outcomes, 2012, 5 (4) :487-493.

[9]Joint Committee for Revision of Chinese Guidelines for Prevention and Treatment of Dyslipidemia in Adults.Chinese guidelines for prevention and treatment of dyslipidemia in adults (revised version in 2016) [J].Chin Circulation J, 2016, 16 (10) :7-28. (in Chinese) 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南 (2016年修订版) [J].中国循环杂志, 2016, 16 (10) :7-28.

[10]ZHANG J, YANG YX, ZHANG WL, et al.An epidemiological investigation of dyslipidemia in Shijingshan District of Beijing, China:An analysis of 32 372 individuals undergoing physical examination[J].Clin J Med Offic, 2017, 45 (9) :950-953. (in Chinese) 张婧, 杨玉霞, 张位龙, 等.北京市石景山区32 372例体检人群血脂异常流行病学调查研究[J].临床军医杂志, 2017, 45 (9) :950-953.

[11] Bureau of Disease Prevention and Control, National Health Commission of the People's Republic of China.Report on Chinese Residents'Chronic Diseases and Nutrition (2015) [M].Beijing:People's Medical Publishing House, 2015. (in Chinese) 国家卫生和计划生育委员会疾病预防控制局.中国居民营养与慢性病状况报告 (2015年) [M].北京:人民卫生出版社, 2015.

[12] MORAN A, GU D, ZHAO D, et al.Future cardiovascular disease in china:Markov model and risk factor scenario projections from the coronary heart disease policy model-china[J].Circ Cardiovasc Qual Outcomes, 2010, 3 (3) :243-252.

[13] DING WQ, DONG HB, MI J.Prevalence of dyslipidemia in Chinese children and adolescents:A Meta-analysis[J].Chin J Epidemiol, 2015, 36 (1) :71-77. (in Chinese) 丁文清, 董虹孛, 米杰.中国儿童青少年血脂异常流行现状Meta分析[J].中华流行病学杂志, 2015, 36 (1) :71-77.

[14]LINDKVIST B, APPELROS S, REGNER S, et al.A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose[J].Pancreatology, 2012, 12 (4) :317-324.

[15]SIMON P, WEISS FU, ZIMMER KP.Acute and chronic pancreatitis in patients with inborn errors of metabolism[J].Pancreatology, 2001, 1 (5) :448-456.

[16]WANG AJ, XU S, HONG JB, et al.The comparison of different clinical scoring systems for predicting prognosis in acute pancreatitis based on the revised Atlanta classification[J].Chin J Intern Med, 2013, 52 (8) :668-671. (in Chinese) 汪安江, 徐思, 洪军波, 等.新亚特兰大分类下不同评分标准预测急性胰腺炎预后的价值比较[J].中华内科杂志, 2013, 52 (8) :668-671.

[17]SCHERER J, SINGH VP, PITCHUMONI CS, et al.Issues in hypertriglyceridemic pancreatitis:An update[J].J Clin Gastroenterol, 2014, 48 (3) :195-203.

[18]VALDIVIELSO P, RAMIREZ-BUENO A, EWALD N.Current knowledge of hypertriglyceridemic pancreatitis[J].Eur J Intern Med, 2014, 25 (8) :689-694.

[19]LANKISCH PG, APTE M, BANKS PA.Acute pancreatitis[J].Lancet, 2015, 386 (9988) :85-96.

[20]BERGLUND L, BRUNZELL JD, GOLDBERG AC, et al.Evaluation and treatment of hypertriglyceridemia:An endocrine society clinical practice guideline[J].J Clin Endocrinol Metab, 2012, 97 (9) :2969-2989.

[21] BERGER Z, QUERA R, PONIACHIK J, et al.Heparin and insulin treatment of acute pancreatitis caused by hypertriglyceridemia.Experience of 5 cases[J].Rev Med Chil, 2001, 129 (12) :1373-1378.

[22]SUN JF, TANG QQ, ZHANG JL, et al.Research advances in the pathogenesis and treatment of hyperlipidemic acute pancreatitis[J].J Hepatobiliary Surg, 2014, 22 (5) :394-396. (in Chinese) 孙俊峰, 汤亲青, 张剑林, 等.高脂血症性急性胰腺炎的发病机制及治疗的研究进展[J].肝胆外科杂志, 2014, 22 (5) :394-396.

[23]MAO EQ, TANG YQ, ZHANG SD.Discussion of normative therapeutic strategy for hyperlipidemic severe acute pancreatitis[J].Chin J Pract Surg, 2003, 23 (9) :542-545. (in Chinese) 毛恩强, 汤耀卿, 张圣道.高脂血症性重症急性胰腺炎规范化治疗方案的探讨[J].中国实用外科杂志, 2003, 23 (9) :542-545.

[24]CATAPANO AL, REINER Z, De BACKER G, et al.ESC/EASGuidelines for the management of dyslipidaemias the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) [J].Atherosclerosis, 2011, 217 (1) :3-46.

施引文献

资源附件(0)

访问统计